SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-028063
Filing Date
2019-08-02
Accepted
2019-08-01 17:51:15
Documents
5
Period of Report
2019-08-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vktx-8k_20190801.htm 8-K 33742
2 EX-5.1 vktx-ex51_7.htm EX-5.1 10263
3 EX-10.1 vktx-ex101_6.htm EX-10.1 228812
4 GRAPHIC g5g1132pfnxa000002.jpg GRAPHIC 2494
5 GRAPHIC g5g1132pfnxa000001.jpg GRAPHIC 2494
  Complete submission text file 0001564590-19-028063.txt   281114
Mailing Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130
Business Address 12340 EL CAMINO REAL, SUITE 250 SAN DIEGO CA 92130 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37355 | Film No.: 19993864
SIC: 2834 Pharmaceutical Preparations